This study evaluated the prognostic significance of continuous on-line vectorcardiography (VCG) during elective coronary angioplasty (percutaneous transluminal coronary angioplasty, PTCA). Patients (n = 192, mean age 58 ± 10), treated with elective and initially successful PTCA, were included. VCG monitoring was started before start of the PTCA procedure and was carried out during the entire procedure. ST vector magnitude (ST-VM) was monitored. A 6-month follow-up was obtained. Main outcome measures were the frequency of cardiac events and revascularization during follow-up. During follow-up, 1 patient died, 6 suffered a nonfatal myocardial infarction and 50 were revascularized. Angiography revealed restenosis in 88% of the patients who had a revascularization. In the total patient group, the VCG predictor of revascularization was the total ischemic time of all ST-VM episodes (p = 0.05). Clinical predictors of revascularization were diabetes mellitus (p < 0.01), a more severe type of lesion (type B; p < 0.01), percent post-PTCA stenosis (p < 0.05), nominal balloon size (p < 0.01), maximum balloon pressure (p < 0.05) and no stent implanted (p < 0.001). In a multivariate analysis all the above significant univariate variables of revascularization were entered. Total ischemic time of ST-VM (p < 0.01) was the best variable giving independent prognostic information. In the nonstent group, total ischemic time of ST-VM (p < 0.01) was the only independent predictor of a further revascularization. In conclusion, VCG monitoring during elective PTCA gives on-line information that identifies patients at an increased risk of a revascularization during 6 months after the initial procedure.

1.
Glazier JJ, Varricchione TR, Ryan TJ, Ruocco NA, Jacobs AK, Faxon DP: Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. Br Heart J 1989;61:485–488.
2.
Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB 3rd, Hamm CW, Puel J, Hueb W, Goy JJ, Rodriguez A: Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184–1189.
3.
Serreys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JH, ten Katen HJ, van Es GA, Hugenholtz PG: Incidence of restenosis after successful coronary angioplasty: A time related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361–372.
4.
Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB Jr, Gruentzig AR: Restenosis after successful coronary angioplasty in patients with single vessel disease. Circulation 1986;73:710–717.
5.
Hasdai D, Bell MR, Grill DE, Berger PB, Garratt KN, Rihal CS, Hammes LV, Holmes DR Jr: Outcome ≥10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79:1005–1011.
6.
Guiteras-Val P, Varas-Lorenzo C, Garcia-Picart J, Marti-Claramunt V, Augé-Sanpera J: Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;83:868–874.
7.
Rensing BJ, Hermans WR, Vos J, Tijssen J, Rutch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serreys PW, on behalf of the Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group: Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural and lesional factors related to long-term angiographic outcome. Circulation 1993;88:975–985.
8.
Wijns W, Serreys PW, Reiber JHC, de Feyter PJ, van den Brand, Simoons ML, Hugenholtz PG: Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise redistribution thallium scintigraphy. Am J Cardiol 1985;55:357–361.
9.
Hoffmann R, Lethen H, Flachskampf FA, Hanrath P: Exercise echocardiography performed early and late after percutaneous transluminal coronary angioplasty for prediction of restenosis. Eur Heart J 1995;16:1872–1879.
10.
Dagianti A, Rosanio S, Penco M, Dagianti A Jr, Sciomer S, Tocchi M, Agati L, Fedele F: Clinical and prognostic usefulness of supine bicycle exercise echocardiography in the functional evaluation of patients undergoing elective percutaneous transluminal coronary angioplasty. Circulation 1997;95:1176–1184.
11.
Jensen SM, Johansson G, Osterman G, Reiz S, Näslund U: On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty: Comparison with 12-lead electrocardiography. Coron Artery Dis 1994;5:507–514.
12.
Holmvang L, Andersen K, Dellborg M, Clemmensen P, Wagner G, Grande P, Abrahamsson P: Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol 1999;83:667–674.
13.
Andersen K, Eriksson P, Dellborg M: Ischaemia detected by continuous on-line vector-cardiographic monitoring predicts unfavourable outcome in patients admitted with probable unstable coronary disease. Coron Artery Dis 1996;7:753–760.
14.
Ryan TJ, Bauman WB, Kennedy JW, Keriakes DJ, King SB 3rd, McCalister BD, Smith SC Jr, Ullyot DJ: Guidelines for percutaneous transluminal angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993;88:2987–3007.
15.
Simpson JB, Baim DS, Robert EW, Harrison DC: A new catheter system for coronary angioplasty. Am J Cardiol 1982;49:1216–1622.
16.
Dellborg M, Emanuelsson H, Riha M, Swedberg K: Dynamic QRS-complex and ST-segment monitoring by continuous vectorcardiography during coronary angioplasty. Coron Artery Dis 1991;2:43–52.
17.
Jensen S, Häggmark S, Johansson G, Näslund U: On-line computerized vectorcardiography: Influence of body position, heart rate, radiographic contrast fluid and myocardial ischemia. Cardiology 1997;88:576–584.
18.
Dodge HT, Sandler H, Baellew DW, Lord JD: The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J 1960;60:762–776.
19.
Stamm RB, Carabello BA, Mayers DL, Martin RP: Two-dimensional echocardiographic measurement of left ventricular ejection fraction: Prospective analysis of what constitutes an adequate determination. Am Heart J 1982;104:136–144.
20.
Horder M, Magid E, Pitkanen E, Harkonen M, Stromme JH, Theodorsen L, Gerhardt W, Waldenstrom J: Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE).Scand J Clin Lab Invest 1979;39:1–5.
21.
Diamond GA: ROC Steady. A receiver operating characteristic curve that is invariant to selection bias. Med Decis Making 1987;7:238–243.
22.
Serruys PW, di Mario C, Piek J, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Flech E, Haude M, Verna E, Geschwind H, Emanuelsson H, Mühlberger V, Danzi G, Peels HD, Ford AJ Jr, Boersma E: Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation 1997;96:3369–3377.
23.
Kern MJ, Dupouy P, Drury JH, Aguirre FV, Aptecar E, Bach RG, Caracciolo EA, Donohue TJ, Rande JL, Geschwind HJ, Mechem CJ, Kane G, Teiger E, Wolford TL: Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: A combined intravascular ultrasound Doppler flow and imaging study. J Am Coll Cardiol 1997;29:1520–1527.
24.
Kern MJ, de Bruyne B, Pijls NH: From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997;30:613–620.
25.
Deligonul U, Vandormael MG, Shah Y, Galan K, Kern MJ, Chaitman BR: Prognostic value of early exercise stress testing after successful coronary angioplasty: Importance of the degree of revascularization. Am Heart J 1989;117:509–514.
26.
Badir BF, LeBlanc AR, Nasmith JB, Palisaitis D, Dube B, Nadeau R: Continuous ST-segment monitoring during coronary angioplasty using orthogonal ECG leads. J Electrocardiol, 1997;30/3:175–187.
27.
Shenasa M, Hamel D, Nasmith J, Nadeau R, Dutoy JL, Derome D, Savard P: Body surface potential mapping of ST-segment shift in patients undergoing percutaneous transluminal coronary angioplasty. J Electrocardiol 1993;26:43–51.
28.
Weyne AE, De Buyzere ML, Bauwens FR, Clement DL: Assessment of myocardial ischemia by 12-lead electrocardiography and Frank vector system during coronary angioplasty: Value of a new orthogonal lead system for quantitative ST segment monitoring. J Am Coll Cardiol 1991;28:1704–1710.
29.
Krucoff MW, Wagner NB, Pope JE, Mortara DM, Jackson YR, Bottner RK, Wagner GS, Kent KM: The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: A preliminary report of a new device for the noninvasive detection of successful reperfusion or silent reocclusion. Am J Cardiol 1990;65:143–148.
30.
Drew BJ, Adams MG, Pelter MM, Shu-Fen W, Caldwell MA: Comparison of standard and derived 12-lead electrocardiograms for diagnosis of coronary angioplasty-induced myocardial ischemia. Am J Cardiol 1997;79:639–644.
31.
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al: The Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489–495.
32.
Kereiakes DJ, Lincoff AM, Miller DP, Tcheng JE, Cabot CF, Anderson KM, Weisman HF, Califf RM, Topol EJ, for the EPILOG Trial Investigators: Abciximab therapy and unplanned coronary stent deployment: Favorable effects on stent use, clinical outcomes and bleeding complications. Circulation 1998;97:857–864.
33.
Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG: Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528–1536.
34.
Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO: Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997;277:461–466.
35.
Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman M: Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241–251.
36.
Kuntz RE, Baim DS: Defining coronary restenosis: Newer clinical and angiographic paradigms. Circulation 1993;88:1310–1323.
37.
Bengtson JR, Mark DB, Honan MB, Rendall DS, Hinohara T, Stack RS, Hlatky MA, Califf RM, Lee KL, Pryor DB: Detection of restenosis after PTCA using the exercise treadmill test. Am J Cardiol 1990;65:28–34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.